Athens, 19 – 20/04/2019

IΑSIS PHARMA participated in the Annual Spring Day Conference of the Hellenic Society of Dermatology and Venereology, proving its dedication in the field of Dermatology.
For 2019, the conference was held at Grand Hyatt Hotel Athens, between April 19th and 20th.

At IASIS PHARMA exhibition stand, HCPs were introduced to three of its main products in the field of Dermatology:

Ιsotroin®, isotretinoin, a retinoid for the treatment of acne, available in 3 strengths: soft caps of 10mg, 20mg and the unique 40mg strength.

Modiwart®, with imiquimod as its active ingredient, is an innovative immunomodulator, with the following indications: external genital warts and anogenital (acuminate warts) in adults, small superficial basal cell carcinomas (sBCC) and clinically typical actinic keratoses (AKs). Modiwart® is distributed in the form of a cream for topical use in 12 sachets package. Each sachet contains 12,5 mg imiquimod in 250 mg cream (5%).

Combi®: a combination of miconazole + fluprednidene in the form of cream with excellent texture and the advantage of the 50g pack.